Which of the following do you usually collect or perform in your RA patients?*
| Measure | Investigation performed (%) | |
|---|---|---|
| Routine RA care (n = 978) | RA patient started on TNF inhibitor (n = 892) | |
| *The table presents the results of two questions wherein the difference was the type of patient (RA v TNF treated RA patient). (Online survey, US rheumatologists, April 2005.) | ||
| †Includes any version of the HAQ (mHAQ, MD-HAQ, Clin-HAQ, etc.). | ||
| ‡Includes any version of the Disease Activity Score (DAS 28, DAS 44, DAS-CRP, etc.). | ||
| CCP, cyclic citrullinated pepaide; HAQ, Health Assessment Questionnaire; ND, no data; PPD, partial purified derivative; RA, rheumatoid arthritis; SJC, swollen joint count; TJC, tender joint count; VAS, visual analogue scale. | ||
| Vital signs | 95.5 | ND |
| Physician overall assessment | ND | 83 |
| Full blood count | 92 | 81.5 |
| Symptom review | 91.9 | ND |
| Morning stiffness | 88.8 | 87.7 |
| Baseline radiographs | 75.4 | ND |
| Joint examination (complaint focused) | 72.8 | 74.7 |
| Erythrocyte sedimentation rate | 68.1 | 79.8 |
| C-reactive protein | 51.8 | 68.3 |
| Tuberculin skin test (PPD) | 48.3 | 59.1 |
| Yearly hand radiographs | 48.3 | 51.1 |
| Hepatitis C antibody | 45.9 | ND |
| Patient global assessment VAS | 45.3 | 39 |
| Patient questionnaire | 45 | 39.3 |
| Antinuclear antibody | 44.6 | ND |
| Patient pain VAS | 43.7 | 50.9 |
| Physician global assessment VAS | 41.9 | 31.8 |
| Rheumatoid factor | 38.3 | 16.4 |
| Hepatitis B surface antigen | 36.4 | ND |
| Cyclic citrullinated peptide antibody | 27.2 | 12.2 |
| Yearly feet radiographs | 27.1 | 23.4 |
| 28 joint count (TJC, SJC) | 27.1 | 27 |
| 66 joint count (TJC, SJC) | 18.8 | 20.4 |
| HAQ (unscored)† | 17.7 | 14.8 |
| HAQ (scored)† | 12.3 | 16.3 |
| Yearly chest radiograph | 16.3 | 20.6 |
| Magnetic resonance imaging | 8.2 | 5.2 |
| Ultrasound | 1.9 | 1.1 |
| Pregnancy test | 7.4 | 7.3 |
| DAS‡ | 6 | 6.5 |
| ACR 20 or ACR-N | 1.8 | 2.8 |